Orgenesis Inc. (NASDAQ:ORGS) Q4 2022 Earnings Call Transcript

Vered Caplan: I don’t think — I mean we are looking and we are expanding regionally, right? So we are putting a big focus this year on expanding capacity in the U.S. And so I hope — we are also expanding in a few other regions, but specifically in the U.S., we put a focus and I hope that will allow us to grow. That’s the goal despite. That’s why we are putting so much effort into this.

Unidentified Analyst: Got it. Thank you so much.

Vered Caplan: Thank you.

Operator: We have reached the end of the question-and-answer session and I will now turn the call over to management for closing remarks.

Vered Caplan: Thank you. I’d like to thank everyone for participating on our year end business update conference call. We are excited about the outlook for the business and appreciate the strong support of our shareholders. We look forward to providing further updates as we advance our therapeutic pipeline, expand our point-of-care platform and deploy our OMPULs worldwide. Thank you.

Operator: This concludes today’s conference and you may disconnect your lines at this time. Thank you for your participation.